Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/20/20
End: 10/01/23
Due: 10/01/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy | NCT05824390 | XIEJINGYUAN | user2@example.com | None | 2020-06-20 | 2023-10-01 | 2024-10-01 | - | - | 2025-07-14 |